Full Press Release Details
WALTHAM, Mass., May 06, 2026 (GLOBE NEWSWIRE) --Crescent Biopharma, Inc.(“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the following investor conferences in May:
• BofA Securities 2026 Healthcare Conference,fireside chat on Wednesday, May 13, 2026 at 4:20 p.m. PT (7:20 p.m. ET) in Las Vegas
• 2026 Stifel Virtual Targeted Oncology Forum,virtual fireside chat on Wednesday, May 20, 2026 at 2:30 p.m. ET
• TD Cowen 7thAnnual Oncology Innovation Summit: Insights for ASCO & EHA,virtual fireside chat on Tuesday, May 26, 2026 at 11:30 a.m. ET
A live webcast of each presentation will be available in the Investors section of Crescent's website athttps://investors.crescentbiopharma.com/events-presentations, and a replay will be accessible for 90 days.About Crescent BiopharmaCrescent Biopharma’s vision is to build a world leading oncology company bringing the next wave of therapies for cancer patients. The Company’s clinical-stage pipeline includes its lead program, a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates (ADCs). By leveraging multiple modalities and established targets, Crescent aims to rapidly advance potentially transformative therapies either as single agents or as part of combination regimens to treat a range of solid tumors. For more information, visitwww.crescentbiopharma.comand follow the Company onLinkedInandX.